Harvard Bioscience Inc (HBIO) is a publicly traded Healthcare sector company. As of July 28, 2026, HBIO trades at $6.11 with a market cap of $27.24M and a P/E ratio of -6.74. HBIO moved +0.75% today. Year to date, HBIO is -8.34%; over the trailing twelve months it is +38.37%. Its 52-week range spans $2.81 to $23.80. Rallies surfaces HBIO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Harvard Bioscience Inc (HBIO) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. HBIO moved +0.75% today.
| Metric | Value |
|---|---|
| Price | $6.11 |
| Market Cap | $27.24M |
| P/E Ratio | -6.74 |
| EPS | $-0.91 |
| Dividend Yield | 0.00% |
| 52-Week High | $23.80 |
| 52-Week Low | $2.81 |
| Volume | 13.07K |
| Avg Volume | 0 |
| Revenue (TTM) | $85.53M |
| Net Income | $-9.78M |
| Gross Margin | 58.42% |
HBIO analyst coverage data. Average price target: $0.00.